x

Coronavirus

CureVac Begun Submitting Data on Its Coronavirus Vaccine to the EU

February 12, 2021

BERLIN — German pharmaceutical company CureVac says it has begun submitting data on its coronavirus vaccine to the EU regulator with the aim of speeding up the approval process.

The Amsterdam-based European Medicines Agency confirmed Friday that it has begun a review of the vaccine and that early laboratory and clinical studies indicate it triggers an immune response against the virus.

Tuebingen-based CureVac is still conducting further trials of the vaccine, but the rolling review process means EMA will be able to reduce the amount of time needed to decide whether to approve it once all the necessary data has been submitted. The same approach led to the approval of vaccines made by Pfizer/BioNTech, Moderna and AstraZeneca.

CureVac’s vaccine uses the same mRNA technology as those made by Pfizer and Moderna.

The company said the vaccine is currently being trialed in healthy adults in Europe and Latin America.

RELATED

MACAO — Only a few tourists crisscrossed the wavy black and white paving of Macao's historic Senado Square on a recent weekday and many of the shops were shuttered.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.